Applied BioCode Corporation (6598.TW)

TWD 19.05

(-0.52%)

Gross Profit Summary of Applied BioCode Corporation

Applied BioCode Corporation's latest annual gross profit in 2023 was 268.73 Million TWD , down -4.54% from previous year.
Applied BioCode Corporation's latest quarterly gross profit in 2024 Q2 was 50.44 Million TWD , up 49.72% from previous quarter.
Applied BioCode Corporation reported a annual gross profit of 234.17 Million TWD in annual gross profit 2022, up 23.66% from previous year.
Applied BioCode Corporation reported a annual gross profit of 189.36 Million TWD in annual gross profit 2021, down -2.15% from previous year.
Applied BioCode Corporation reported a quarterly gross profit of 41 Million TWD for 2024 Q1, down -55.22% from previous quarter.
Applied BioCode Corporation reported a quarterly gross profit of 91.57 Million TWD for 2023 Q4, up 28.36% from previous quarter.

Annual Gross Profit Chart of Applied BioCode Corporation (2023 - 2013)

Historical Annual Gross Profit of Applied BioCode Corporation (2023 - 2013)

Year	Gross Profit	Gross Profit Growth
2023	268.73 Million TWD	-4.54%
2022	234.17 Million TWD	23.66%
2021	189.36 Million TWD	-2.15%
2020	193.52 Million TWD	265.35%
2019	52.96 Million TWD	216.57%
2018	16.73 Million TWD	87.7%
2017	8.91 Million TWD	82.1%
2016	4.89 Million TWD	-21.57%
2015	6.24 Million TWD	128.94%
2014	2.72 Million TWD	35.02%
2013	2.01 Million TWD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	50.44 Million TWD	49.72%
2024 Q1	41 Million TWD	-55.22%
2023 Q4	91.57 Million TWD	28.36%
2023 FY	223.53 Million TWD	-4.54%
2023 Q1	53.23 Million TWD	-27.45%
2023 Q2	41.08 Million TWD	-22.82%
2023 Q3	71.34 Million TWD	73.64%
2022 FY	234.17 Million TWD	23.66%
2022 Q1	23.13 Million TWD	-69.62%
2022 Q4	73.37 Million TWD	11.34%
2022 Q3	65.9 Million TWD	-8.17%
2022 Q2	71.76 Million TWD	210.2%
2021 Q4	76.14 Million TWD	169.56%
2021 Q2	29.25 Million TWD	-47.5%
2021 Q1	55.71 Million TWD	-42.92%
2021 FY	189.36 Million TWD	-2.15%
2021 Q3	28.24 Million TWD	-3.43%
2020 FY	193.52 Million TWD	265.35%
2020 Q4	97.6 Million TWD	50.84%
2020 Q3	64.7 Million TWD	2050.42%
2020 Q2	3 Million TWD	-89.33%
2020 Q1	28.2 Million TWD	146.06%
2019 Q3	15.79 Million TWD	119.41%
2019 FY	52.96 Million TWD	216.57%
2019 Q1	18.47 Million TWD	187.68%
2019 Q2	7.19 Million TWD	-61.03%
2019 Q4	11.46 Million TWD	-27.43%
2018 Q2	4.22 Million TWD	0.0%
2018 FY	16.73 Million TWD	87.7%
2018 Q4	6.42 Million TWD	245.22%
2018 Q3	1.86 Million TWD	-55.98%
2018 Q1	4.22 Million TWD	61.71%
2017 Q3	2.61 Million TWD	41.7%
2017 Q2	1.84 Million TWD	0.0%
2017 Q4	2.61 Million TWD	0.0%
2017 Q1	1.84 Million TWD	0.0%
2017 FY	8.91 Million TWD	82.1%
2016 Q4	- TWD	0.0%
2016 Q2	185 Thousand TWD	0.0%
2016 FY	4.89 Million TWD	-21.57%
2015 FY	6.24 Million TWD	128.94%
2015 Q4	- TWD	0.0%
2014 FY	2.72 Million TWD	35.02%
2013 FY	2.01 Million TWD	0.0%

Peer Gross Profit Comparison of Applied BioCode Corporation

Name	Gross Profit	Gross Profit Difference
Excelsior Medical Co., Ltd.	1.62 Billion TWD	83.433%
Apex Medical Corp.	1.13 Billion TWD	76.392%
OK Biotech Co., Ltd.	196.88 Million TWD	-36.496%